Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus

Todd W. Gress, F. Javier Nieto, Eyal Shahar, Marion R. Wofford, Frederick L. Brancati

Research output: Contribution to journalArticle

885 Citations (Scopus)

Abstract

Background: Previous research has suggested that thiazide diuretics and beta-blockers may promote the development of type 2 diabetes mellitus. However, the results of these studies have been inconsistent, and many studies have been limited by inadequate data on outcomes and by potential confounding. Methods: We conducted a prospective study of 12,550 adults 45 to 64 years old who did not have diabetes. An extensive health evaluation conducted at base line included assessment of medication use and measurement of blood pressure with a random-zero sphygmomanometer. The incidence of new cases of diabetes was assessed after three years and after six years by measurement of serum glucose concentrations while the subjects were fasting. Results: After simultaneous adjustment for age, sex, race, education, adiposity, family history with respect to diabetes, physical-activity level, other health-related behavior, and coexisting illnesses, subjects with hypertension who were taking thiazide diuretics were not at greater risk for the subsequent development of diabetes than were subjects with hypertension who were not receiving any antihypertensive therapy (relative hazard, 0.91; 95 percent confidence interval, 0.73 to 1.13). Likewise, subjects who were taking angiotensin-converting-enzyme inhibitors and calcium-channel antagonists were not at greater risk than those not taking any medication. In contrast, subjects with hypertension who were taking beta-blockers had a 28 percent higher risk of subsequent diabetes (relative hazard, 1.28; 95 percent confidence interval, 1.04 to 1.57). Conclusions: Concern about the risk of diabetes should not discourage physicians from prescribing thiazide diuretics to nondiabetic adults who have hypertension. The use of beta-blockers appears to increase the risk of diabetes, but this adverse effect must be weighed against the proven benefits of beta-blockers in reducing the risk of cardiovascular events. (C) 2000, Massachusetts Medical Society.

Original languageEnglish (US)
Pages (from-to)905-912
Number of pages8
JournalNew England Journal of Medicine
Volume342
Issue number13
DOIs
StatePublished - Mar 30 2000
Externally publishedYes

Fingerprint

Type 2 Diabetes Mellitus
Antihypertensive Agents
Hypertension
Sodium Chloride Symporter Inhibitors
Therapeutics
Confidence Intervals
Sphygmomanometers
Illness Behavior
Sex Education
Medical Societies
Adiposity
Calcium Channel Blockers
Angiotensin-Converting Enzyme Inhibitors
Health Status
Fasting
Prospective Studies
Exercise
Blood Pressure
Physicians
Glucose

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. / Gress, Todd W.; Nieto, F. Javier; Shahar, Eyal; Wofford, Marion R.; Brancati, Frederick L.

In: New England Journal of Medicine, Vol. 342, No. 13, 30.03.2000, p. 905-912.

Research output: Contribution to journalArticle

Gress, Todd W. ; Nieto, F. Javier ; Shahar, Eyal ; Wofford, Marion R. ; Brancati, Frederick L. / Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. In: New England Journal of Medicine. 2000 ; Vol. 342, No. 13. pp. 905-912.
@article{4fee2163698a4d64851ce870b4e7735f,
title = "Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus",
abstract = "Background: Previous research has suggested that thiazide diuretics and beta-blockers may promote the development of type 2 diabetes mellitus. However, the results of these studies have been inconsistent, and many studies have been limited by inadequate data on outcomes and by potential confounding. Methods: We conducted a prospective study of 12,550 adults 45 to 64 years old who did not have diabetes. An extensive health evaluation conducted at base line included assessment of medication use and measurement of blood pressure with a random-zero sphygmomanometer. The incidence of new cases of diabetes was assessed after three years and after six years by measurement of serum glucose concentrations while the subjects were fasting. Results: After simultaneous adjustment for age, sex, race, education, adiposity, family history with respect to diabetes, physical-activity level, other health-related behavior, and coexisting illnesses, subjects with hypertension who were taking thiazide diuretics were not at greater risk for the subsequent development of diabetes than were subjects with hypertension who were not receiving any antihypertensive therapy (relative hazard, 0.91; 95 percent confidence interval, 0.73 to 1.13). Likewise, subjects who were taking angiotensin-converting-enzyme inhibitors and calcium-channel antagonists were not at greater risk than those not taking any medication. In contrast, subjects with hypertension who were taking beta-blockers had a 28 percent higher risk of subsequent diabetes (relative hazard, 1.28; 95 percent confidence interval, 1.04 to 1.57). Conclusions: Concern about the risk of diabetes should not discourage physicians from prescribing thiazide diuretics to nondiabetic adults who have hypertension. The use of beta-blockers appears to increase the risk of diabetes, but this adverse effect must be weighed against the proven benefits of beta-blockers in reducing the risk of cardiovascular events. (C) 2000, Massachusetts Medical Society.",
author = "Gress, {Todd W.} and Nieto, {F. Javier} and Eyal Shahar and Wofford, {Marion R.} and Brancati, {Frederick L.}",
year = "2000",
month = "3",
day = "30",
doi = "10.1056/NEJM200003303421301",
language = "English (US)",
volume = "342",
pages = "905--912",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "13",

}

TY - JOUR

T1 - Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus

AU - Gress, Todd W.

AU - Nieto, F. Javier

AU - Shahar, Eyal

AU - Wofford, Marion R.

AU - Brancati, Frederick L.

PY - 2000/3/30

Y1 - 2000/3/30

N2 - Background: Previous research has suggested that thiazide diuretics and beta-blockers may promote the development of type 2 diabetes mellitus. However, the results of these studies have been inconsistent, and many studies have been limited by inadequate data on outcomes and by potential confounding. Methods: We conducted a prospective study of 12,550 adults 45 to 64 years old who did not have diabetes. An extensive health evaluation conducted at base line included assessment of medication use and measurement of blood pressure with a random-zero sphygmomanometer. The incidence of new cases of diabetes was assessed after three years and after six years by measurement of serum glucose concentrations while the subjects were fasting. Results: After simultaneous adjustment for age, sex, race, education, adiposity, family history with respect to diabetes, physical-activity level, other health-related behavior, and coexisting illnesses, subjects with hypertension who were taking thiazide diuretics were not at greater risk for the subsequent development of diabetes than were subjects with hypertension who were not receiving any antihypertensive therapy (relative hazard, 0.91; 95 percent confidence interval, 0.73 to 1.13). Likewise, subjects who were taking angiotensin-converting-enzyme inhibitors and calcium-channel antagonists were not at greater risk than those not taking any medication. In contrast, subjects with hypertension who were taking beta-blockers had a 28 percent higher risk of subsequent diabetes (relative hazard, 1.28; 95 percent confidence interval, 1.04 to 1.57). Conclusions: Concern about the risk of diabetes should not discourage physicians from prescribing thiazide diuretics to nondiabetic adults who have hypertension. The use of beta-blockers appears to increase the risk of diabetes, but this adverse effect must be weighed against the proven benefits of beta-blockers in reducing the risk of cardiovascular events. (C) 2000, Massachusetts Medical Society.

AB - Background: Previous research has suggested that thiazide diuretics and beta-blockers may promote the development of type 2 diabetes mellitus. However, the results of these studies have been inconsistent, and many studies have been limited by inadequate data on outcomes and by potential confounding. Methods: We conducted a prospective study of 12,550 adults 45 to 64 years old who did not have diabetes. An extensive health evaluation conducted at base line included assessment of medication use and measurement of blood pressure with a random-zero sphygmomanometer. The incidence of new cases of diabetes was assessed after three years and after six years by measurement of serum glucose concentrations while the subjects were fasting. Results: After simultaneous adjustment for age, sex, race, education, adiposity, family history with respect to diabetes, physical-activity level, other health-related behavior, and coexisting illnesses, subjects with hypertension who were taking thiazide diuretics were not at greater risk for the subsequent development of diabetes than were subjects with hypertension who were not receiving any antihypertensive therapy (relative hazard, 0.91; 95 percent confidence interval, 0.73 to 1.13). Likewise, subjects who were taking angiotensin-converting-enzyme inhibitors and calcium-channel antagonists were not at greater risk than those not taking any medication. In contrast, subjects with hypertension who were taking beta-blockers had a 28 percent higher risk of subsequent diabetes (relative hazard, 1.28; 95 percent confidence interval, 1.04 to 1.57). Conclusions: Concern about the risk of diabetes should not discourage physicians from prescribing thiazide diuretics to nondiabetic adults who have hypertension. The use of beta-blockers appears to increase the risk of diabetes, but this adverse effect must be weighed against the proven benefits of beta-blockers in reducing the risk of cardiovascular events. (C) 2000, Massachusetts Medical Society.

UR - http://www.scopus.com/inward/record.url?scp=0034732256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034732256&partnerID=8YFLogxK

U2 - 10.1056/NEJM200003303421301

DO - 10.1056/NEJM200003303421301

M3 - Article

C2 - 10738048

AN - SCOPUS:0034732256

VL - 342

SP - 905

EP - 912

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 13

ER -